4
Changes in Ownership
Cogent Biosciences, Inc. Filed Acc 0001209191-20-041017
Options or other derivatives
- Director acquired 35,280 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Ros Matthew Director | 2020-07-01 | Grant or award · Stock Option (Right to Buy) | +35,280 | $0.31 | $11,000 | 35,280 | D |
Loading xslF345X03/doc4.xml…